A novel anti-rheumatic drug suppresses tumor necrosis factor-α and augments interleukin-10 in adjuvant arthritic rats

被引：23

作者：

Hisadome, M ^{[1
]}

Fukuda, T ^{[1
]}

Sumichika, H ^{[1
]}

Hanano, T ^{[1
]}

Adachi, K ^{[1
]}

机构：

[1] Welfide Corp, Res Labs, Yoshitomi, Fukuoka 8718550, Japan

来源：

EUROPEAN JOURNAL OF PHARMACOLOGY | 2000年 / 409卷 / 03期

关键词：

Y-39041; arthritis; TNF-alpha (tumor necrosis factor-alpha); interleukin-10; lipopolysaccharide;

D O I：

10.1016/S0014-2999(00)00866-9

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Tumor necrosis factor-alpha (TNF-alpha) plays an important role in the pathology of rheumatoid arthritis. When N-[1-(4-([4-(pyrimidin-2-yl)piperazin-1-yl]methyl)phenyl)cyclopropyl]acetamide (Y-39041) (3-30 mg/kg) was orally administered to rats with established arthritis from day 15 to day 20, hindpaw volume was significantly reduced. This inhibitory activity of Y-39041 was kept up after administration was stopped. On day 17 Y-39041 suppressed lipopolysaccharide-induced TNF-alpha and interleukin-6 production in serum at doses of 3-30 mg/kg, and augmented interleukin-10 production at doses of 10 and 30 mg/kg. The finding that Y-39041 suppresses TNF-alpha and interleukin-6 production and augments interleukin-10 production could be beneficial in the therapy of chronic inflammatory diseases. (C) 2000 Elsevier Science B.V. All rights reserved.

引用

页码：331 / 335

页数：5

共 17 条

[1]

Badger AM, 1996, J PHARMACOL EXP THER, V279, P1453

[2] Anti-arthritic activity of hydroxamic acid-based pseudopeptide inhibitors of matrix metalloproteinases and TNF alpha processing [J].

DiMartino, M ;

Wolff, C ;

High, W ;

Stroup, G ;

Hoffman, S ;

Laydon, J ;

Lee, JC ;

Bertolini, D ;

Galloway, WA ;

Crimmin, MJ ;

Davis, M ;

Davies, S .

INFLAMMATION RESEARCH, 1997, 46 (06) :211-215

[3] Role of cytokines in rheumatoid arthritis [J].

Feldmann, M ;

Brennan, FM ;

Maini, RN .

ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :397-440

[4]

FIORENTINO DF, 1991, J IMMUNOL, V147, P3815

[5] A novel dual regulator of tumor necrosis factor-α and interleukin-10 protects mice from endotoxin-induced shock [J].

Fukuda, T ;

Sumichika, H ;

Murata, M ;

Hanano, T ;

Adachi, K ;

Hisadome, M .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 391 (03) :317-320

[6] Cellular adhesion molecules in rat adjuvant arthritis [J].

Halloran, MM ;

Szekanecz, Z ;

Barquin, N ;

Haines, GK ;

Koch, AE .

ARTHRITIS AND RHEUMATISM, 1996, 39 (05) :810-819

[7] Novel DMARDs on the basis of a new concept of dual cytokine regulation, TNF-α suppression and IL-10 augmentation [J].

Hanano, T ;

Adachi, K ;

Aoki, Y ;

Morimoto, H ;

Naka, Y ;

Hisadome, M ;

Fukuda, T ;

Sumichika, H .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (09) :881-884

[8]

Maetzel A, 1998, J RHEUMATOL, V25, P2331

[9]

Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO

[10]

2-W

← 1 2 →